Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sarepta Therapeutics (SRPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,996,719
  • Shares Outstanding, K 64,630
  • Annual Sales, $ 5,420 K
  • Annual Income, $ -267,270 K
  • 36-Month Beta 1.37
  • Price/Sales 34.04
  • Price/Cash Flow N/A
  • Price/Book 5.64

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.35 +18.91%
on 01/08/18
62.96 -1.13%
on 01/18/18
+8.04 (+14.83%)
since 12/19/17
3-Month
46.07 +35.12%
on 10/26/17
62.96 -1.13%
on 01/18/18
+11.53 (+22.73%)
since 10/19/17
52-Week
26.26 +137.05%
on 02/13/17
62.96 -1.13%
on 01/18/18
+28.02 (+81.86%)
since 01/19/17

Most Recent Stories

More News
Sarepta Therapeu Shares Up 77.2% Since SmarTrend's Buy Recommendation (SRPT)

SmarTrend identified an Uptrend for Sarepta Therapeu (NASDAQ:SRPT) on June 21st, 2017 at $34.53. In approximately 7 months, Sarepta Therapeu has returned 77.18% as of today's recent price of $61.17.

SRPT : 62.35 (+0.82%)
First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that the first Duchenne patient has been dosed with microdystrophin...

SRPT : 62.35 (+0.82%)
Today's Research Reports on Trending Tickers: Sarepta Therapeutics and Valeant Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / January 11, 2018 / All three major indexes dropped Wednesday on news that China is considering halting the purchases of U.S. sovereign debt, with the S&P 500 and Nasdaq logging...

SRPT : 62.35 (+0.82%)
VRX : 21.53 (-2.58%)
Sarepta Therapeu Set to Possibly Pullback After Yesterday's Rally of 4.27%

Sarepta Therapeu (NASDAQ:SRPT) traded in a range yesterday that spanned from a low of $55.86 to a high of $59.50. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high...

SRPT : 62.35 (+0.82%)
Sarepta Therapeutics Pre-Announces Fourth Quarter 2017 Revenue and Provides Full-Year 2018 Revenue Guidance for EXONDYS 51(R) (eteplirsen), Representing Approximately 100 Percent Year-over-Year Growth

-- Fourth quarter 2017 EXONDYS 51 unaudited revenue of $57.3 million --

SRPT : 62.35 (+0.82%)
Today's Research Reports on Stocks to Watch: Sarepta Therapeutics and Valeant Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / January 8, 2018 / Shares of Sarepta Therapeutics fell over 5% this past Friday. It was revealed that the company's former CEO is now heading a new local start up called Stoke...

SRPT : 62.35 (+0.82%)
VRX : 21.53 (-2.58%)
Sarepta Therapeu Shares Up 68.7% Since SmarTrend's Buy Recommendation (SRPT)

SmarTrend identified an Uptrend for Sarepta Therapeu (NASDAQ:SRPT) on June 21st, 2017 at $34.53. In approximately 7 months, Sarepta Therapeu has returned 68.72% as of today's recent price of $58.25.

SRPT : 62.35 (+0.82%)
Sarepta Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases, today...

SRPT : 62.35 (+0.82%)
JPM : 113.01 (-0.22%)
Sarepta Therapeutics Announces Publication of Long-Term Pulmonary Function of Eteplirsen-Treated Patients Compared to Natural History of Duchenne Muscular Dystrophy in The Journal of Neuromuscular Diseases

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases, today...

SRPT : 62.35 (+0.82%)
SmarTrend Watching for Potential Pullback in Shares of Sarepta Therapeu After 1.27% Gain

Sarepta Therapeu (NASDAQ:SRPT) traded in a range yesterday that spanned from a low of $54.01 to a high of $55.29. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high...

SRPT : 62.35 (+0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Sarepta Therapeutics, Inc. focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy. Sarepta Therapeutics, Inc., formerly known as AVI BioPharma,...

See More

Key Turning Points

2nd Resistance Point 64.16
1st Resistance Point 63.00
Last Price 62.35
1st Support Level 60.64
2nd Support Level 59.44

See More

52-Week High 62.96
Last Price 62.35
Fibonacci 61.8% 48.94
Fibonacci 50% 44.61
Fibonacci 38.2% 40.28
52-Week Low 26.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.